Abstract
Energy deficit is characterised by high ghrelin levels, and low leptin and insulin levels and we suggest that this provides a metabolic signature sensed by the brain to increase motivated behaviour to obtain food. We believe that the hormonal profile of negative energy balance serves to increase the incentive salience (or the value) of a food reinforcer, which in turn leads to increased motivation to obtain this reinforcer. These processes are mediated by a number of alterations in the mesolimbic dopamine system which serves to increase dopamine availability in the forebrain during energy deficit. The currently available evidence suggests that changes in motivational state, rather than hedonic enjoyment of taste, are primarily affected by reduced energy availability. This review aims to clarify the term ‘reward’ in the metabolic literature and promote more focused discussion in future studies.
Keywords: Reward, Motivation, Dopamine, Feeding, Behaviour, Ghrelin
1. Introduction
1.1. Defining ‘reward’
The concept of reward is applied widely but is often poorly defined [1], and these problems with labelling extend into the literature around food reward [2]. The scientific term ‘reward’ essentially has three possible meanings as outlined by Sanchis-Segura and Spanegal [3]. It can describe stimuli with a desirable outcome, as the term is usually applied in a lay sense. This is also known as a reinforcer. It can describe the acquisition of a learned response, which earns a positive outcome, also known as contingency learning or positive reinforcement. Finally, it can refer to an inferred internal pleasurable or hedonic state, which occurs once the reward has been obtained or consumed [3]. The argument could be made that these are all part of a bigger picture of an overarching ‘reward pathway’, but the overlap in terminology can lead to confusion and errors in analysis. Certainly, the role that mesolimbic dopamine plays in motivational processes is more complex and nuanced than is often credited in the literature, and the blanket term ‘reward pathway’ is somewhat misleading [1]. This review will endeavour to use the term ‘reinforcer’, ‘positive reinforcement’ and ‘hedonic state’ as they are discussed above to avoid confusion with the term ‘reward’.
1.2. Computing value: incentive salience
The core role of mesolimbic dopamine in eating deals with the motivational aspects of food-seeking rather than the hedonic value of consumption or the ability to learn associations between stimulus and outcome. Mice completely lacking dopaminergic signalling (dopamine deficient, DD, mice) still show a preference for sucrose solution over water [4] and remember the location of treats in a T maze [5], indicating that dopamine is not critical for these processes. In both these studies the DD mice showed deficits in how much work they were willing to do to obtain the reward, also known as wanting or appetitive drive. The idea that this aspect of reward processing is most affected by dopaminergic signalling has been discussed at length by others [6,7], so suffice to say here it is becoming more clear that the role of mesolimbic dopamine, broadly speaking, is to encode the process by which an animal assesses the value of the reinforcer against the cost of obtaining it. The value of a reinforcer is not a static representation, and can be influenced by a number of factors such as the internal state of the animal. This concept of the internal representation of the value of a reinforcer at this moment in time is known as ‘incentive salience’ [6].
There are a number of studies that document how changes in physiological need lead to changes in incentive salience of a reinforcer, or how valuable a reinforcer is perceived to be. Under normal circumstances rats do not enjoy a saline solution, but under conditions of experimentally-induced sodium depletion they experience a neuronal response similar to that of ingesting sucrose [8]. Similarly, when monkeys are water deprived their willingness to work for a water reinforcer correlates with the osmolality of their blood, with the animals becoming disinterested in working for a water reinforcer as their blood osmolality approaches normal [9]. These examples highlight the way the incentive salience (or perceived value) of a reinforcer can be acutely recomputed de novo with each presentation of that reinforcer [6], and show that the value ascribed is dependent on physiological need. In both these examples, one suggested driver for the shift in the incentive salience of the reinforcer offered is blood osmolality – changes that are sensed by the brain and then produce goal directed behaviour to reinstate appropriate blood solute levels.
1.3. Hunger as an amplifier of incentive salience
This idea that changes in internal environment can be sensed and can influence the value of a reinforcer clearly holds much relevance to regulation of feeding, as organisms have been eating for almost as long as they have been maintaining fluid balance. Negative energy balance is characterised by low levels of plasma leptin, insulin and glucose and high levels of plasma ghrelin and free fatty acids. This humoral state signals to the brain a net energy deficit, which sets off a number of adaptive strategies for regaining neutral or positive energy balance. Some of the more complex behavioural outcomes of this humoral milieu involve changes to motivation and incentive salience of reinforcers, particularly, although surprisingly not exclusively, food reinforcers.
In flavour preference paradigms where rats are given a preferred reinforcer, such as a sucrose solution, paired with particular flavour, such as grape, they quickly come to prefer grape flavour compared to another flavour which had been paired with water. This is true for both caloric reinforcers such as sucrose and ethanol, and non-caloric ones such as saccharine or caffeine [10]. When hungry, rats show an increased preference for those flavours previously paired with reinforcers containing calories (ethanol, sucrose) while no greater preference is observed with flavours that were previously paired with non-nutritive reinforcers such as saccharine or caffeine [10,11]. This indicates that the physiological state of negative energy balance increases the incentive salience of presumed caloric content of a flavour previously paired with calories. This concept is further supported by evidence that satiety signals – hormones that when endogenously released signal replete energy stores – suppress intake of calorie-paired flavours. The exogenous administration of the gut hormone cholecystokinin (CCK) robustly suppresses feeding in hungry animals, and similarly suppresses consumption of a previously ethanol-paired flavour in hungry rats [12]. This kind of motivational manipulation by humoral hunger and satiety signals has been shown in a range of behavioural paradigms and with a number of hormones. Indeed, this supports the idea that the brain senses a ‘blueprint’ of energy deficit or surplus from the blood, which then informs the organism of the value a food reinforcer by altering motivation or drive.
Studies looking at how food deprivation can shift motivational state offer a basis for trying to uncover the signalling mechanism that causes these shifts in motivation. Fasting decreases both the activity and mRNA expression of the dopamine transporter (DAT) [13], and chronic food restriction increases binding at the D2 receptor [14], supporting the idea that increased dopaminergic signalling is important in the biological response to a fast. A better understanding of the pathways by which metabolic need gets translated into focused, motivated, food seeking behaviour is developing; however, there is still much to be learned. This review will focus on important humoral factors that signal nutrient availability to the brain: insulin, leptin, and ghrelin, in an effort to examine how hypothalamic nutrient sensing mechanisms influence incentive salience and motivational drive under different metabolic states.
2. Ghrelin
Ghrelin is the only circulating factor known to increase food intake, and plasma levels are high with fasting and in prolonged food deprivation. Ghrelin plays a broad role in protecting the organism from the consequences of negative energy balance, such as maintaining blood glucose levels during starvation [15,16], as well promoting feeding through a number of pathways. It is well documented that circulating ghrelin acts on agouti regulated peptide/neuropeptide Y (AgRP/NPY)-expressing neurons in the arcuate nucleus (ARC) of the hypothalamus to promote feeding, an effect that is largely considered a homoeostatic response to decreased nutrient availability. Ghrelin's ability to promote feeding extends to actions on extrahypothalamic pathways, and recent evidence suggests that high ghrelin levels may be a primary driver to alter the incentive salience of food, and thus the motivation to work toward reinforcers, in response to a high metabolic need for food. Ghrelin given to rats either centrally or peripherally increases their motivation to work for a palatable food reinforcer in a bar press task, meaning that the rats are willing to work harder for longer to obtain the sucrose reinforcer [17,18]. However, similar administration of ghrelin did not affect the lick rate and/or lick rate interval of a sucrose solution. As an increase in lick rate and a decrease in the intervals between lick bouts indicates increased hedonic enjoyment of consumption [18], these results suggest ghrelin does not affect the hedonic experience of consumption.
The ghrelin-induced increase in the lever pressing task is blocked by dopamine D1 receptor antagonists while the same treatment does not alter lick architecture, in line with the known properties of dopamine to promote motivation rather than hedonic states [18]. It also suggests that the value the animal places on a caloric reinforcer is under the influence of ghrelin signalling, indicating that ghrelin may indeed mediate shifts in incentive salience of calories. Others have previously shown that ghrelin promotes consumption of calorically dense foods over palatable foods, and come to the conclusion that ghrelin is not promoting ‘reward’ but rather signalling information on energy density of food [19], fitting with the idea that ghrelin is important in determining the value of a calorie at the moment of ingestion.
Others have suggested a motivational role for ghrelin [20] on the basis of the observation that ghrelin administration into the third ventricle directly increases locomotor activity and dopamine overflow in the nucleus accumbens (NAc). This observation that locomotor activity is increased following ghrelin administration disagrees with previous findings showing that ICV ghrelin decreases locomotor activity [21], however as Jerlhag et al. point out a fundamental difference between these two studies is the presence of food when ghrelin-elicited locomotor activity was assessed. When food is present, there is no locomotor response to ghrelin, while in the absence of food locomotor activity increases robustly. More recent studies demonstrated that direct activation of the canonical target neuronal population of ghrelin, arcuate AgRP/NPY neurons, shows the same pattern. Using DREADD technology to acutely activate NPY/AgRP neurons significantly increases locomotor activity in the absence of food, but no change is observed when food is present [22]. Of particular interest to this review, the same paper showed direct activation of the NPY/AgRP neurons significantly increased the breakpoint in a nose poke task to obtain a food reinforcer, showing that the mice had increased motivation to work for food. Importantly, the acute increase in NPY/AgRP neural activity elevated breakpoint to that seen in fasted mice. As NPY/AgRP neurons are more active under negative energy balance [15,23] this suggests that NPY/AgRP neurons are a key target population to connect metabolic status with the incentive salience of food. The increased locomotor activity is interpreted as food-seeking behaviour, as this only happens in the absence of food. Two classical side effects of increased dopamine levels are altered locomotor activity, and increased motivated responding [1,24,25], so it seems entirely possible that ghrelin, acting through NPY/AgRP neurons, increases mesolimbic dopamine levels thereby altering the incentive salience of food.
NPY/AgRP neurons signal using two separate neuropeptides, AgRP and NPY, and use GABA as their neurotransmitter [26]. These three signalling pathways are all sensitive to ghrelin, and work to promote feeding through a complex, distributed network of downstream targets [27–29].
Administration of exogenous AgRP promotes behaviours associated with fat consumption, at the expense of those associated with sugar consumption. Centrally administered AgRP promotes responding for a fat reinforcer in preference to a sucrose one, a reversal of the preference shown by saline-treated rats [30]. Moreover, treatment with AgRP during conditioning period blocks formation of a conditioned place preference for sucrose, but not pelleted high fat diet [31]. Others show that AgRP administration promotes consumption of chow in preference to even relatively concentrated sucrose solutions [32], suggesting it directs consumptive behaviour toward fats or fat to carbohydrate ratio – cues that may indicate greater caloric density. In contrast to these effects of AgRP, ghrelin increases responding for a sucrose reinforcer [17,33], an effect dependent on NPY signalling and opioid neuropeptide transmission in the VTA [33]. Interestingly, opioid receptor antagonism blocks the increase in chow consumption seen with AgRP administration [32,34], although the specific brain regions involved in this have not been described. Recent evidence describes a clear role for kappa opioid receptor (KOR) involvement in the hypothalamus-mediated effects of ghrelin-induced feeding, rather than mesolimibic mediated processes [35]. Complete suppression of AgRP-induced feeding is seen with sub-threshold doses of combined selective KOR and mu opioid receptor (MOR) antagonists [34], suggesting that multiple, overlapping opioid driven circuits regulate downstream effects of ghrelin and NPY/AgRP neuronal signalling.
Recent studies demonstrate that NPY/AgRP neurons innervate the ventral tegmental area (VTA) and directly modulate the dopaminergic neurons via GABA-ergic signalling [36]. VTA dopamine neurons terminate in a number of forebrain areas and contribute to a range of behaviours and processes. Somewhat counterintuitively, lowering NPY/AgRP neuronal activity using SIRT1 deletion reduced inhibitory control over VTA dopaminergic neurons, meaning that NPY/AgRP neurons apparently exhibit tonic inhibition on this population. NPY/ AgRP neurons project extensively throughout the brain [37], and likely affect multiple end processes. GABAergic inhibition from this population onto the parabracial nuclus (PBN) is critical for feeding behaviour and it is not surprising that ablation/suppression of NPY/AgRP neurons would similarly lead to dis-inhibition in both populations. The NPY/AgRP system is extremely plastic, as ablation of this population in adulthood results in death by starvation [38,39], however neonatal ablation [39], or germline deletion [40] are extremely well tolerated. Given this, congenital suppression of NPY/AgRP signalling after SIRT1 deletion in these neurons may increase dopaminergic tone as a compensatory mechanism for reduced drive to eat.
The ghrelin receptor (growth hormone secretagogue receptor; GHSR) is found throughout the brain. In addition to being present on NPY/AgRP neurons, it is co-expressed with dopamine D1 receptors in a number of cell populations and the two receptors appear to have functional interaction, at least in vitro [41]. A number of sites within the reward pathway are sensitive to ghrelin administration with both intra- VTA and NAc ghrelin inducing feeding behaviour [42]. In a number of behavioural paradigms ghrelin has reinforcing effects. Ghrelin increases the conditioned preference for chambers paired with palatable food in the conditioned place preference tests, and suppression of ghrelin signalling in GHSR1a knockout mice attenuates the formation of a preference [43]. Ghrelin also increases breakpoint in progressive ratio tasks, where satiated mice treated with ghrelin show increased motivation to respond for a high fat food pellet. This effect appears to require orexin signalling, as it is absent in orexin-deficient mice [43], however the GHSR1a mRNA is not present in the lateral hypothalamus where the orexin neurons are situated [44,45], suggesting that ghrelin affects these neurons via an indirect pathway. Indeed, orexin-containing neurons receive dense NPY/AgRP projections from the ARC [46] and are extremely sensitive to AgRP [47], so this action of ghrelin presumably acts via an AgRP/NPY neuronal circuit.
The VTA is directly sensitive to ghrelin with direct injection of ghrelin into the VTA increasing feeding, and peripheral ghrelin injection increasing dopamine turnover in the ventral striatum [48]. Ghrelin injected into the VTA results in increased motivated responding to a food reinforcer [49], indicating that circulating ghrelin impacts motivational response through direct action in the VTA. Recently, this has been demonstrated to be dependent on signalling via D1 and D2 receptors in the nucleus accumbens (NAc), where pharmacological blockade of these receptors attenuates lever pressing, but not chow intake following VTA ghrelin administration [50]. This argues for divergent ghrelin-sensitive neurocircuitry originating in the VTA, which differentially promotes feeding and motivated responding.
If food is present and animals are freely consuming it, there is no way to separate out the various drivers of that consumption. It may be hedonic, it may be motivational, and it may be ‘homoeostatic’ hunger drive. It is only through creating situations where these individual components can be measured that we can gauge their contribution to the overall effect of increased feeding. Ghrelin clearly plays a role in multiple aspects of ingestive behaviour [51] however the evidence does support a strong role for motivational processes in its orexigeneic effects, driven by altered valuation or increased incentive salience of food reinforcers. We suggest the canonical homoeostatic pathway of ghrelin acting via the NPY/AgRP neurons in all likelihood signals via the VTA to promote consumption of energy dense foods, an effect dependant on opioid signalling. Circulating ghrelin also reaches the VTA directly, and can increase both feeding and motivated responding, although the downstream pathways are divergent. Taken together, the hypothalamic and mesolimbic pathways represent a convergent evolution of ghrelin function, which promotes positive energy balance through both increased food intake and increased motivational drive to obtain food.
3. Insulin and leptin
High circulating ghrelin levels are accompanied by low insulin and leptin levels in situations of energy deficit. Low levels of these hormones likely serve to promote activation of various reward and motivational processes, which is similar to the processes described above for ghrelin, signalling through both hypothalamic and VTA pathways. Both the leptin and insulin receptors are expressed on dopaminergic neurons within the VTA [52,53] and ICV administration of either leptin or insulin suppresses responding for a sucrose reinforcer in satiated chow-fed rats [54]. The concept that the relative fluctuating levels of insulin and leptin influence the incentive salience of a food reinforcer is neatly demonstrated by the way rats respond to insulin or leptin treatment in the conditioned place preference (CPP) test. For example, animals treated with ICV insulin or leptin on the test day of a CPP test show reduced preference for the side paired with an energy dense food reinforcer compared to vehicle treated rats, regardless of whether they were treated with leptin or insulin during the conditioning phase. However, rats treated with leptin or insulin during conditioning, but not treated on the test day, show the same preference as vehicle treated rats for the side paired with the food reinforcer [55]. This demonstrates that high levels of brain leptin or insulin do not block the ability of the rats to learn about the caloric content and possibly hedonic impact of the food, however high levels of brain insulin and leptin during testing reduce the value or how salient calorie content is to the animal, which manifests as reduced preference for the paired chamber.
Both NPY/AgRP and proopiomelanocortin (POMC) neurons in the hypothalamus are direct targets of leptin and insulin. At normal circulating leptin levels, leptin receptors on the AgRP neurons provide tonic inhibition on these neurons [23]. Removal of this inhibition when leptin levels fall, results in increased excitability of these neurons, which acts in addition to ghrelin's excitatory action at these cells. Furthermore, studies by Perello et al. show GHSR1a deficiency does not influence leptin's effects on appetite and body weight [56], however central leptin infusion prevents Fos activation in the arcuate nucleus of the hypothalamus (ARC) in response to GHSR1a agonism [57]. These results suggest hierarchical neuroendocrine control over NPY/AgRP neurons, as removal of leptin tonic inhibition is required to fully maximise ghrelin-induced activation of NPY/AgRP neurons.
The main hypothalamic neuronal type responsible for leptin's anorexigenic effects is presynaptic GABA-ergic cells that maintain inhibitory control over the POMC cells [58]. These cells do not contain AgRP, although NPY/AgRP cells are also GABA-ergic and have inhibitory inputs onto POMC neurons [59], with cell bodies in the ARC, the DMH, and/or the lateral hypothalamus (LH) [58]. When leptin is present, i.e., in fed conditions, leptin action on these GABA-ergic cells results in disinhibition of POMC neurons. When leptin signalling is removed from these GABA-ergic neurons, the downstream POMC cells become hyperpolarised and cease providing opposition to NPY/AgRP signalling, resulting in increased feeding and obesity [58]. In this way, leptin may also influence signalling through AgRP-mediated motivational effects.
The LH has been described as a key linking nucleus for hypothalamic, mesolimbic and cortical structures [60]. Electrical stimulation of the LH is pleasurable and conditions an operant response, possibly due to the extensive innervation of the VTA from this area [60]. There are leptin receptor-containing neurons in the LH which project to the VTA and mediate tyrosine hydroxylase expression [61]. These neurons contain neurotensin and are a distinct population from the well-described orexin and melanin concentration hormone (MCH) containing populations, although projections within the LH regulate orexin neuronal function [61,62]. The LH receives projections from the arcuate nucleus, as mentioned above, as well as the nucleus accumbens, and insular and cingulate cortices, all areas heavily involved with higher processing of food-related behaviour [63]. Neurons in the LH are also glucose sensing, with MCH neurons being excited by increased glucose and orexin neurons being inhibited [64,65]. Taken together, this suggests that the LH is in a key position to integrate cortical information about higher order behavioural outcomes with base metabolic information conveyed via hypothalamic circuits.
Both the insulin and leptin receptors heavily co-localise with tyrosine hydroxylase staining in the VTA [52,66] and exogenous administration of leptin and insulin into the brain can directly modulate dopaminergic signalling [67]. Fasting decreases DAT activity, which can be reversed in vitro in cell preparations by incubation with insulin [13]. Further to this, intra-VTA insulin injections increase activity of the dopamine transporter (DAT) and reduce dopamine availability in the VTA [68]. While this study did not examine the effects of VTA insulin in forebrain structures more likely to directly mediate motivated behaviour, others have shown that ablating insulin production with streptozotocin (STZ) decreases DAT activity, and thus increases dopamine availability in the striatum [69]. This appears to have functional consequences as STZ-treated rats show increased susceptibility to forming a conditioned place preference to morphine [70], similar to effects seen in DAT knockout mice, which also display constitutively high dopamine levels.
Leptin directly modulates the responsiveness of midbrain dopaminergic neurons. Using pSTAT3 as a marker of leptin activated cells, both the dopaminergic and GABA-ergic population have been shown to be leptin responsive, with a relatively greater proportion of TH positive cells showing pSTAT3 staining [66,71]. At least some of these pSTAT3 positive cells project to the NAc [71], and leptin administration reduces both firing rate of dopamine neurons [66] and dopamine efflux in the NAc [72]. Knockdown of the leptin receptor within the VTA by siRNA increases responding for a sucrose reinforcer on a progressive ratio task [73]. Interestingly, knockdown of this leptin receptor population does not affect fixed ratio responding [73] or sucrose preference in a free choice two bottle paradigm [74], consistent with the idea that reduced leptin signalling in the VTA primarily influences motivational drive rather than hedonic consumption. These receptors also mediate anxiety-related behaviour [74] through signalling to the amygdala, another target structure of the VTA dopaminergic neurons.
In rats, refeeding following a fast is associated with a NAc dopamine spike, which is suppressed when rats are given leptin before refeeding [72]. Intact dopamine signalling is critical for the motivation to eat [75], even in the absence of leptin, a situation that usually drives extreme hyperphagia [76]. Conversely, viral knockdown of the leptin receptor in the VTA of mice results in increased feeding and locomotor activity [66]. These findings suggest that the ability of leptin to suppress feeding is predicated on an intact dopaminergic system as the ultimate effector mechanism to drive consumption.
4. Opioid signalling in motivation and hedonics
The VTA and associated neural circuits are generally considered the backbone of the reward pathway. The VTA receives input from LH [60], as well as from the nucleus of the solitary tract (NTS) in the brainstem [77], an area which integrates afferent signals from the viscera. As mentioned above, it is directly sensitive to leptin and insulin levels and VTA neurons are sensitive to glucose [78]. Closely associated with VTA neurocircuitry are the opioid receptors. Opioid receptors, particularly the MOR, are often associated with hedonic processing, but the opioid receptors are widely expressed throughout the brain and have broad involvement in many processes including homoeostatically driven feeding behaviour. Alternative post-translational processing of POMC yields beta endorphin, an agonist for the inhibitory G protein coupled MOR [79]. Beta endorphin released from POMC cells inhibits POMC neurons via autoreceptors [80,81] as well as likely inhibiting NPY/AgRP neuronal activity [82]. In both the POMC and NPY/AgRP populations, it has been speculated that beta endorphin serves to shut down persistent neural activity, so opioid signalling within the hypothalamus may form part of a local regulatory circuit.
Opioid receptor expression within the VTA regulates dopaminergic tone and can modulate motivational processes. Injection of MOR agonists into the VTA increases dopamine release in the NAc [83], and increases feeding in fasted rats and satiated rats [84,85]. Recent work has shown that opioid and dopamine signalling in the NAc can amplify incentive salience of cues [86], so it may be that metabolic signals act to increase baseline drive, and opioid and dopaminergic signalling in the NAc further promotes motivated behaviour. The possibility that amplification of an incentive salience signal by the NAc may push cue-dependent motivated behaviour may have implications for failure of diets designed to induce weight loss, as fMRI imaging shows hungry human subjects also have enhanced appetitive cue-responses [87]. In this situation, dopaminergic amplification of the incentive salience of food cues in the NAc may make those cues impossible to resist, leading to 'cheating' on the diet.
The hedonic aspects of the eating experience seem to stem from the NAc which generates the hedonic response to metabolically relevant taste stimuli, such as sweet and fatty [88]. The involvement of opioid receptors in the ventral striatum in such processes has been known for some time [89], but recent work has localised this phenomena to a small area in the medial shell of the NAc, which has been named the ‘hedonic hotspot’ [90]. Opioid signalling in this ‘hotspot’ mediates feeding behaviour, with opioid agonists increasing the ‘liking’ of a sweet taste and inducing feeding [90]. A similar area exists within the interconnected ventral pallidum [91]. These responses seem particularly to rely upon signalling by the MOR, although cannabinoid receptor 1 activation in this area is also able to produce increased hedonic reactions to taste [92]. There is a little doubt that opioid activation in areas of the NAc shell is associated with heightened enjoyment of food and eating [93], however whether metabolic signals modulate this response is unclear. As pointed out recently, ‘the difference between dopamine and mu opioid effects in the NAc is not that opioids always cause increased ‘liking’ but not ‘wanting’, whereas dopamine causes ‘wanting’ but not ‘liking’’ [86], rather the relationship is much more complex. Currently, there is a lack of empirical evidence to support the idea of metabolic modulation of pure hedonic reaction to taste, however it will be interesting to see if such modulation can be demonstrated. There is some evidence that fasting enhances the ability to detect sweet or salty taste in solution in humans, with different methodologies confirming [94] or debunking the idea [95]. Diurnal leptin levels have been linked to the ability to detect sweet taste, with greater sensitivity achieved when leptin levels are low [96]. Similar reports have been made regarding olfactory acuity in rats, where fasted rats show greater ability than satiated rats to detect both neutral and aversive odours [97,98]. Administration of insulin blunts this effect, rendering fasted rats no better at odour detection than satiated ones and abolishing sniffing in response to food odour [98]. High ghrelin levels similarly have a sensitising effect and enhance sniffing behaviour in both rodents and humans, but do not alter pleasantness as rated by human subjects [99]. Critically, in both rodents and humans the sensitisation occurs regardless of hedonic impact of the scent, demonstrating a general heightening of sensation and/or perception of scent, and not increased hedonic experience. At present, there is a lack of evidence to support the idea that metabolic signals alter hedonic impact of food reinforcers, or of taste sensations, however this is an area that deserves more study.
5. Conclusion
Energy deficit serves to alter motivational state by increasing the incentive salience of certain reinforcers. This fact has been exploited widely in behavioural research to encourage animals to perform or learn a task they are otherwise disinclined to do. How the brain senses internal energy status and transduces that signal into increased motivation is not clear. We postulate that the hormonal signature of hunger (i.e. high ghrelin and low leptin and insulin levels) serves as a metabolic signature that promotes increased dopaminergic signalling, most prominently through modulation of dopamine uptake. This ultimately manifests as increased motivation to work for a reinforcer, and serves to alter the incentive salience of food in line with metabolic need. Motivation and reinforcer value are the mesolimbic processes most affected by metabolic needs. There is little evidence that hunger, or the hormonal signature of hunger, increases in hedonic impact of food through heightened enjoyment of taste. It is possible that this hormonal signature works to a more than additive, possibly synergistic, amplification of motivation particularly through the opposing actions of the hormones leptin and ghrelin in a number of neural circuits. The example of NPY/AgRP neurons, which are activated by high ghrelin levels and disinhibited by low leptin levels, demonstrates that these signals can act in a co-ordinated way to produce increased drive to eat. Additionally, there are other hormonal signals such as GLP-1 and amylin which are known to act in reward pathways and may provide further levels of augmentation of the motivational response to energy deficit. Both of these hormones are satiety signals and can signal through the VTA to reduce feeding [77,100], and also modulate motivated responding [100,101]. In addition, there may be direct actions of altered humoral fatty acid and/or glucose levels on neuronal populations responsible for parsing motivation. The way in which these signals interact with the hormones discussed here remains to be examined.
As outlined in Section 1, using the catch-all term of ‘reward’ to describe all mesolimbic processes has led to confusion in the literature. Others have made a concerted effort to disambiguate the term and to provide a lexicon to describe the complex behaviours encapsulated within the broader concept of ‘reward’ [2,3]. In summary, we believe that a metabolic signature of energy deficit, such as high ghrelin and low leptin and insulin, increases the incentive salience or the value of a food reinforcer. The idea that metabolic need alters ‘reward’ processing is misleading, and careful consideration and reporting of the exact mesolimbic processes being manipulated will greatly benefit the field of metabolic science.
Conflict of interest
We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
Footnotes
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
References
- 1.Salamone J.D., Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron. 2012;76(3):470–485. doi: 10.1016/j.neuron.2012.10.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Salamone J.D., Correa M. Dopamine and food addiction: lexicon badly needed. Biological Psychiatry. 2013;73(9):e15–24. doi: 10.1016/j.biopsych.2012.09.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sanchis-Segura C., Spanagel R. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addiction Biology. 2006;11(1):2–38. doi: 10.1111/j.1369-1600.2006.00012.x. [DOI] [PubMed] [Google Scholar]
- 4.Cannon C.M., Palmiter R.D. Reward without dopamine. Journal of Neuroscience. 2003;23(34):10827–10831. doi: 10.1523/JNEUROSCI.23-34-10827.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Robinson S. Distinguishing whether dopamine regulates liking, wanting, and/or learning about rewards. Behavioral Neuroscience. 2005;119(1):5–15. doi: 10.1037/0735-7044.119.1.5. [DOI] [PubMed] [Google Scholar]
- 6.Berridge K.C. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology. 2007;191(3):391–431. doi: 10.1007/s00213-006-0578-x. [DOI] [PubMed] [Google Scholar]
- 7.Salamone J.D. Dopamine, behavioral economics, and effort. Frontiers in Behavioral Neuroscience. 2012;3(13):1–12. doi: 10.3389/neuro.08.013.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Tindell A.J. Dynamic computation of incentive salience: wanting what was never liked. Journal of Neuroscience. 2009;29(39):12220–12228. doi: 10.1523/JNEUROSCI.2499-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Minamimoto T. Hydration level is an internal variable for computing motivation to obtain water rewards in monkeys. Experimental Brain Research. 2012;218(4):609–618. doi: 10.1007/s00221-012-3054-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fedorchak P.M. Caffeine-reinforced conditioned flavor preferences in rats. Behavioral Neuroscience. 2002;116(2):334–346. [PubMed] [Google Scholar]
- 11.Fedorchak P.M., Bolles R.C. Hunger enhances the expression of calorie-mediated but not taste-mediated conditioned flavor preferences. Journal of Experimental Psychology-Animal Behavior Processes. 1987;13(1):73–79. [PubMed] [Google Scholar]
- 12.Fedorchak P.M., Bolles R.C. Nutritive expectancies mediate cholecystokinins suppression-of-intake effect. Behavioral Neuroscience. 1988;102(3):451–455. doi: 10.1037//0735-7044.102.3.451. [DOI] [PubMed] [Google Scholar]
- 13.Patterson T.A. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology. 1998;68(1):11–20. doi: 10.1159/000054345. [DOI] [PubMed] [Google Scholar]
- 14.Thanos P.K. Food restriction markedly increases dopamine d2 receptor (D2R) in a rat model of obesity as assessed with in-vivo mu PET Imaging (C-11 raclopride) and in-vitro ( H-3 spiperone) autoradiography. Synapse. 2008;62(1):50–61. doi: 10.1002/syn.20468. [DOI] [PubMed] [Google Scholar]
- 15.Briggs D.I., Andrews Z.B. Metabolic status regulates ghrelin function on energy homeostasis. Neuroendocrinology. 2011;93(1):48–57. doi: 10.1159/000322589. [DOI] [PubMed] [Google Scholar]
- 16.Zhao T.J. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(16):7467–7472. doi: 10.1073/pnas.1002271107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Skibicka K.P. Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addiction Biology. 2012;17(1):95–107. doi: 10.1111/j.1369-1600.2010.00294.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Overduin J. Ghrelin increases the motivation to eat, but does not alter food palatability. American Journal of Physiology-Regulatory Integrative and Comparative Physiology. 2012;303(3):R259–R269. doi: 10.1152/ajpregu.00488.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bomberg E.M. Central ghrelin induces feeding driven by energy needs not by reward. Neuroreport. 2007;18(6):591–595. doi: 10.1097/WNR.0b013e3280b07bb5. [DOI] [PubMed] [Google Scholar]
- 20.Jerlhag E. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addiction Biology. 2006;11(1):45–54. doi: 10.1111/j.1369-1600.2006.00002.x. [DOI] [PubMed] [Google Scholar]
- 21.Tang-Christensen M. Central administration of ghrelin and Agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology. 2004;145(10):4645–4652. doi: 10.1210/en.2004-0529. [DOI] [PubMed] [Google Scholar]
- 22.Krashes M.J. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. Journal of Clinical Investigation. 2011;121(4):1424–1428. doi: 10.1172/JCI46229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Takahashi K.A., Cone R.D. Fasting induces a large, leptin-dependent increase in the intrinsic action potential frequency of orexigenic arcuate nucleus neuropeptide Y/Agouti-related protein neurons. Endocrinology. 2005;146(3):1043–1047. doi: 10.1210/en.2004-1397. [DOI] [PubMed] [Google Scholar]
- 24.Puglisi-Allegra S., Cabib S. Psychopharmacology of dopamine: the contribution of comparative studies in inbred strains of mice. Progress in Neurobiology. 1997;51(6):637–661. doi: 10.1016/s0301-0082(97)00008-7. [DOI] [PubMed] [Google Scholar]
- 25.Castro R. Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval. Psychopharmacology. 1985;85(3):333–339. doi: 10.1007/BF00428198. [DOI] [PubMed] [Google Scholar]
- 26.Chen P.L. Altered expression of Agouti-related protein and its colocalization with neuropeptide Y in the arcuate nucleus of the hypothalamus during lactation. Endocrinology. 1999;140(6):2645–2650. doi: 10.1210/endo.140.6.6829. [DOI] [PubMed] [Google Scholar]
- 27.Andrews Z.B. Central mechanisms involved in the orexigenic actions of ghrelin. Peptides. 2011;32(11):2248–2255. doi: 10.1016/j.peptides.2011.05.014. [DOI] [PubMed] [Google Scholar]
- 28.Cowley M.A. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37(4):649–661. doi: 10.1016/s0896-6273(03)00063-1. [DOI] [PubMed] [Google Scholar]
- 29.Wu Q., Clark M.S., Palmiter R.D. Deciphering a neuronal circuit that mediates appetite. Nature. 2012;483(7391):594–597. doi: 10.1038/nature10899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Tracy A.L. The melanocortin antagonist AgRP (83-132) increases appetitive responding for a fat, but not a carbohydrate, reinforcer. Pharmacology Biochemistry and Behavior. 2008;89(3):263–271. doi: 10.1016/j.pbb.2007.12.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Davis J.F. Central melanocortins modulate mesocorticolimbic activity and food seeking behavior in the rat. Physiology & Behavior. 2011;102(5):491–495. doi: 10.1016/j.physbeh.2010.12.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hagan M.M. Opioid receptor involvement in the effect of AgRP-(83-132) on food intake and food selection. American Journal of Physiology-Regulatory Integrative and Comparative Physiology. 2001;280(3):R814–R821. doi: 10.1152/ajpregu.2001.280.3.R814. [DOI] [PubMed] [Google Scholar]
- 33.Skibicka K.P. Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward. Endocrinology. 2012;153(3):1194–1205. doi: 10.1210/en.2011-1606. [DOI] [PubMed] [Google Scholar]
- 34.Brugman S. Combined blockade of both mu- and kappa-opioid receptors prevents the acute orexigenic action of agouti-related protein. Endocrinology. 2002;143(11):4265–4270. doi: 10.1210/en.2002-220230. [DOI] [PubMed] [Google Scholar]
- 35.Romero-Pico A. Hypothalamic kappa-opioid receptor modulates the orexigenic effect of ghrelin. Neuropsychopharmacology. 2013;38(7):1296–1307. doi: 10.1038/npp.2013.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Dietrich M.O. AgRP neurons regulate development of dopamine neuronal plasticity and nonfood-associated behaviors. Nature Neuroscience. 2012;15(8):1108. doi: 10.1038/nn.3147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Broberger C. The neuropeptide Y agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(25):15043–15048. doi: 10.1073/pnas.95.25.15043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Wu Q., Boyle M.P., Palmiter R.D. Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell. 2009;137(7):1225–1234. doi: 10.1016/j.cell.2009.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Luquet S. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science. 2005;310(5748):683–685. doi: 10.1126/science.1115524. [DOI] [PubMed] [Google Scholar]
- 40.Qian S. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Molecular and Cellular Biology. 2002;22(14):5027–5035. doi: 10.1128/MCB.22.14.5027-5035.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Jiang H., Betancourt L., Smith R.G. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Molecular Endocrinology. 2006;20(8):1772–1785. doi: 10.1210/me.2005-0084. [DOI] [PubMed] [Google Scholar]
- 42.Naleid A.M. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides. 2005;26(11):2274–2279. doi: 10.1016/j.peptides.2005.04.025. [DOI] [PubMed] [Google Scholar]
- 43.Perello M. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biological Psychiatry. 2010;67(9):880–886. doi: 10.1016/j.biopsych.2009.10.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Guan X.M. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Molecular Brain Research. 1997;48(1):23–29. doi: 10.1016/s0169-328x(97)00071-5. [DOI] [PubMed] [Google Scholar]
- 45.Zigman J.M. Expression of ghrelin receptor mRNA in the rat and the mouse brain. Journal of Comparative Neurology. 2006;494(3):528–548. doi: 10.1002/cne.20823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Broberger C. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and Agouti gene-related protein systems. Journal of Comparative Neurology. 1998;402(4):460–474. [PubMed] [Google Scholar]
- 47.Zheng H.Y. Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP. American Journal of Physiology-Regulatory Integrative and Comparative Physiology. 2002;282(6):R1773–R1781. doi: 10.1152/ajpregu.00019.2002. [DOI] [PubMed] [Google Scholar]
- 48.Abizaid A. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. Journal of Clinical Investigation. 2006;116(12):3229–3239. doi: 10.1172/JCI29867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Skibicka K.P. Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience. 2011;180:129–137. doi: 10.1016/j.neuroscience.2011.02.016. [DOI] [PubMed] [Google Scholar]
- 50.Skibicka K.P. Divergent circuitry underlying food reward and intake effects of ghrelin: dopaminergic VTA-accumbens projection mediates ghrelin's effect on food reward but not food intake. Neuropharmacology. 2013;73C:274–283. doi: 10.1016/j.neuropharm.2013.06.004. [DOI] [PubMed] [Google Scholar]
- 51.Schellekens H., Dinan T.G., Cryan J.F. Ghrelin at the interface of obesity and reward. In: Litwack G., editor. Obesity. Elsevier Academic Press Inc; San Diego: 2013. pp. 285–323. [DOI] [PubMed] [Google Scholar]
- 52.Figlewicz D.P. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Research. 2003;964(1):107–115. doi: 10.1016/s0006-8993(02)04087-8. [DOI] [PubMed] [Google Scholar]
- 53.Konner A.C. Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metabolism. 2011;13(6):720–728. doi: 10.1016/j.cmet.2011.03.021. [DOI] [PubMed] [Google Scholar]
- 54.Figlewicz D.P. Intraventricular insulin and leptin decrease sucrose self-administration in rats. Physiology & Behavior. 2006;89(4):611–616. doi: 10.1016/j.physbeh.2006.07.023. [DOI] [PubMed] [Google Scholar]
- 55.Figlewicz D.P. Intraventricular insulin and leptin reverse place preference conditioned with high-fat diet in rats. Behavioral Neuroscience. 2004;118(3):479–487. doi: 10.1037/0735-7044.118.3.479. [DOI] [PubMed] [Google Scholar]
- 56.Perello M. Functional implications of limited leptin receptor and ghrelin receptor coexpression in the brain. Journal of Comparative Neurology. 2012;520(2):281–294. doi: 10.1002/cne.22690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Hewson A.K. The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic. Diabetes. 2002;51(12):3412–3419. doi: 10.2337/diabetes.51.12.3412. [DOI] [PubMed] [Google Scholar]
- 58.Vong L. Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron. 2011;71(1):142–154. doi: 10.1016/j.neuron.2011.05.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Cowley M.A. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411(6836):480–484. doi: 10.1038/35078085. [DOI] [PubMed] [Google Scholar]
- 60.Berthoud H.R., Munzberg H. The lateral hypothalamus as integrator of metabolic and environmental needs: from electrical self-stimulation to opto-genetics. Physiology & Behavior. 2011;104(1):29–39. doi: 10.1016/j.physbeh.2011.04.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Leinninger G.M. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metabolism. 2009;10(2):89–98. doi: 10.1016/j.cmet.2009.06.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Leinninger G.M. Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. Cell Metabolism. 2011;14(3):313–323. doi: 10.1016/j.cmet.2011.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Kampe J. An anatomic basis for the communication of hypothalamic, cortical and mesolimbic circuitry in the regulation of energy balance. European Journal of Neuroscience. 2009;30(3):415–430. doi: 10.1111/j.1460-9568.2009.06818.x. [DOI] [PubMed] [Google Scholar]
- 64.Moriguchi T. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neuroscience Letters. 1999;264(1–3):101–104. doi: 10.1016/s0304-3940(99)00177-9. [DOI] [PubMed] [Google Scholar]
- 65.Burdakov D., Gerasimenko O., Verkhratsky A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. Journal of Neuroscience. 2005;25(9):2429–2433. doi: 10.1523/JNEUROSCI.4925-04.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Hommel J.D. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron. 2006;51(6):801–810. doi: 10.1016/j.neuron.2006.08.023. [DOI] [PubMed] [Google Scholar]
- 67.Spielewoy C. Increased rewarding properties of morphine in dopamine-transporter knockout mice. European Journal of Neuroscience. 2000;12(5):1827–1837. doi: 10.1046/j.1460-9568.2000.00063.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Mebel D.M. Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake. European Journal of Neuroscience. 2012;36(3):2336–2346. doi: 10.1111/j.1460-9568.2012.08168.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Owens W.A. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. Journal of Neurochemistry. 2005;94(5):1402–1410. doi: 10.1111/j.1471-4159.2005.03289.x. [DOI] [PubMed] [Google Scholar]
- 70.Samandari R. Streptozotocin-induced diabetes affects the development and maintenance of morphine reward in rats. Neuroscience Letters. 2013;543:90–94. doi: 10.1016/j.neulet.2013.03.024. [DOI] [PubMed] [Google Scholar]
- 71.Fulton S. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron. 2006;51(6):811–822. doi: 10.1016/j.neuron.2006.09.006. [DOI] [PubMed] [Google Scholar]
- 72.Krugel U. Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. European Journal of Pharmacology. 2003;482(1–3):185–187. doi: 10.1016/j.ejphar.2003.09.047. [DOI] [PubMed] [Google Scholar]
- 73.Davis J.F. Leptin regulates energy balance and motivation through action at distinct neural circuits. Biological Psychiatry. 2011;69(7):668–674. doi: 10.1016/j.biopsych.2010.08.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Liu J. Selective deletion of the leptin receptor in dopamine neurons produces anxiogenic-like behavior and increases dopaminergic activity in amygdala. Molecular Psychiatry. 2011;16(10):1024–1038. doi: 10.1038/mp.2011.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Szczypka M.S. Feeding behavior in dopamine-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(21):12138–12143. doi: 10.1073/pnas.96.21.12138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Szczypka M.S., Rainey M.A., Palmiter R.D. Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nature Genetics. 2000;25(1):102–104. doi: 10.1038/75484. [DOI] [PubMed] [Google Scholar]
- 77.Alhadeff A.L., Rupprecht L.E., Hayes M.R. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology. 2012;153(2):647–658. doi: 10.1210/en.2011-1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Marinelli S. Pharmacological identification of the K+ currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurones. Neuropharmacology. 2000;39(6):1021–1028. doi: 10.1016/s0028-3908(99)00186-0. [DOI] [PubMed] [Google Scholar]
- 79.Law P.Y., Loh H.H. Regulation of opioid receptor activities. Journal of Pharmacology and Experimental Therapeutics. 1999;289(2):607–624. [PubMed] [Google Scholar]
- 80.Kelly M.J., Loose M.D., Ronnekleiv O.K. Opioids hyperpolarize beta-endorphin neurons via mu-receptor activation of a potassium conductance. Neuroendocrinology. 1990;52(3):268–275. doi: 10.1159/000125597. [DOI] [PubMed] [Google Scholar]
- 81.Loose M.D., Ronnekleiv O.K., Kelly M.J. Neurons in the rat arcuate nucleus are hyperpolarized by gaba-b and mu-opioid receptor agonists – evidence for convergence at a ligand-gated potassium conductance. Neuroendocrinology. 1991;54(6):537–544. doi: 10.1159/000125979. [DOI] [PubMed] [Google Scholar]
- 82.Yang Y.L. Hunger states switch a flip–flop memory circuit via a synaptic AMPK-dependent positive feedback loop. Cell. 2011;146(6):991–1002. doi: 10.1016/j.cell.2011.07.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America. 1992;89(6):2046–2050. doi: 10.1073/pnas.89.6.2046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Noel M.B., Wise R.A. Ventral tegmental injections of morphine but not u-50,488h enhance feeding in food-deprived rats. Brain Research. 1993;632(1–2):68–73. doi: 10.1016/0006-8993(93)91139-j. [DOI] [PubMed] [Google Scholar]
- 85.Mucha R.F., Iversen S.D. Increased food-intake after opioid microinjections into nucleus-accumbens and ventral tegmental area of rat. Brain Research. 1986;397(2):214–224. doi: 10.1016/0006-8993(86)90622-0. [DOI] [PubMed] [Google Scholar]
- 86.Pecina S., Berridge K.C. Dopamine or opioid stimulation of nucleus accumbens similarly amplify cue-triggered ‘wanting’ for reward: entire core and medial shell mapped as substrates for PIT enhancement. European Journal of Neuroscience. 2013;37(9):1529–1540. doi: 10.1111/ejn.12174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Dagher A. Functional brain imaging of appetite. Trends in Endocrinology and Metabolism. 2012;23(5):250–260. doi: 10.1016/j.tem.2012.02.009. [DOI] [PubMed] [Google Scholar]
- 88.Will M.J., Franzblau E.B., Kelley A.E. Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. Journal of Neuroscience. 2003;23(7):2882–2888. doi: 10.1523/JNEUROSCI.23-07-02882.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Kelley A.E. Opioid modulation of taste hedonics within the ventral striatum. Physiology & Behavior. 2002;76(3):365–377. doi: 10.1016/s0031-9384(02)00751-5. [DOI] [PubMed] [Google Scholar]
- 90.Pecina S., Berridge K.C. Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness? Journal of Neuroscience. 2005;25(50):11777–11786. doi: 10.1523/JNEUROSCI.2329-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Smith K.S., Berridge K.C. The ventral pallidum and hedonic reward: Neurochemical maps of sucrose ‘liking’ and food intake. Journal of Neuroscience. 2005;25(38):8637–8649. doi: 10.1523/JNEUROSCI.1902-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Mahler S.V., Smith K.S., Berridge K.C. Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances ‘liking’ of sweet reward. Neuropsychopharmacology. 2007:1–12. doi: 10.1038/sj.npp.1301376. [DOI] [PubMed] [Google Scholar]
- 93.Pecina S., Smith K.S. Hedonic and motivational roles of opioids in food reward: implications for overeating disorders. Pharmacology Biochemistry and Behavior. 2010;97(1):34–46. doi: 10.1016/j.pbb.2010.05.016. [DOI] [PubMed] [Google Scholar]
- 94.Zverev Y.P. Effects of caloric deprivation and satiety on sensitivity of the gustatory system. BMC Neuroscience. 2004;5(5) doi: 10.1186/1471-2202-5-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Pasquet P. Relationship between taste thresholds and hunger under debate. Appetite. 2006;46(1):63–66. doi: 10.1016/j.appet.2005.09.004. [DOI] [PubMed] [Google Scholar]
- 96.Nakamura Y. Diurnal variation of human sweet taste recognition thresholds is correlated with plasma leptin levels. Diabetes. 2008;57(10):2661–2665. doi: 10.2337/db07-1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Aime P. Fasting increases and satiation decreases olfactory detection for a neutral odor in rats. Behavioural Brain Research. 2007;179(2):258–264. doi: 10.1016/j.bbr.2007.02.012. [DOI] [PubMed] [Google Scholar]
- 98.Aime P. A physiological increase of insulin in the olfactory bulb decreases detection of a learned aversive odor and abolishes food odor-induced sniffing behavior in rats. Plos One. 2012;7:12. doi: 10.1371/journal.pone.0051227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Tong J. Ghrelin enhances olfactory sensitivity and exploratory sniffing in rodents and humans. Journal of Neuroscience. 2011;31(15):5841–5846. doi: 10.1523/JNEUROSCI.5680-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Mietlicki-Baase E.G. Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake. Neuropsychopharmacology. 2013;38(9):1685–1697. doi: 10.1038/npp.2013.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Dickson S.L. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. Journal of Neuroscience. 2012;32(14):4812–4820. doi: 10.1523/JNEUROSCI.6326-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]